Literature DB >> 22064941

Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Susan A Masino1, Masahito Kawamura, David N Ruskin, Jeremy Gawryluk, Xuesong Chen, Jonathan D Geiger.   

Abstract

Ketogenic diets are high in fat and low in carbohydrates and represent a well-established and effective treatment alternative to anti-epileptic drugs. Ketogenic diets are used for the management of a variety of difficult-to-treat or intractable seizure disorders, especially pediatric refractory epilepsy. However, it has been shown that this dietary therapy can reduce seizures in people of all ages, and ketogenic diets are being applied to other prevalent medical conditions such as diabetes. Although used effectively to treat epilepsy for nearly 90 years, the mechanism(s) by which ketogenic diets work to reduce seizures remain ill-understood. One mechanism receiving increased attention is based on findings that ketogenic diets increase the brain energy molecule ATP, and may also increase the levels and actions of the related endogenous inhibitory neuromodulator adenosine. ATP and adenosine have both been identified as important modulators of seizures; seizures increase the actions of these purines, these purines regulate epileptic activity in brain, adenosine receptor antagonists are pro-convulsant, and adenosinergic mechanisms have been implicated previously in the actions of approved anti-epileptic therapeutics. Here we will review recent literature and describe findings that shed light on mechanistic relationships between ketogenic diets and the purines ATP and adenosine. These emerging mechanisms hold great promise for the effective therapeutic management of epileptic seizures and other neurological conditions.

Entities:  

Year:  2010        PMID: 22064941      PMCID: PMC3207247          DOI: 10.2174/1874082001004010058

Source DB:  PubMed          Journal:  Open Neurosci J


  109 in total

1.  Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine.

Authors:  S A Masino; T V Dunwiddie
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  Ketogenic diet in patients with myoclonic-astatic epilepsy.

Authors:  Roberto Horacio Caraballo; Ricardo Oscar Cersósimo; Diego Sakr; Araceli Cresta; Nidia Escobal; Natalio Fejerman
Journal:  Epileptic Disord       Date:  2006-06       Impact factor: 1.819

Review 3.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

4.  Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.

Authors:  Tianfu Li; Gaoying Ren; David L Kaplan; Detlev Boison
Journal:  Epilepsy Res       Date:  2009-02-12       Impact factor: 3.045

5.  Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.

Authors:  Carl E Stafstrom; Jeffrey C Ockuly; Lauren Murphree; Matthew T Valley; Avtar Roopra; Thomas P Sutula
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 6.  Clinical aspects of the ketogenic diet.

Authors:  Adam L Hartman; Eileen P G Vining
Journal:  Epilepsia       Date:  2007-01       Impact factor: 5.864

7.  [Effect of ketogenic diet on the convulsive threshold and brain amino acid and monoamine levels in young mice].

Authors:  K Otani; A Yamatodani; H Wada; T Mimaki; H Yabuuchi
Journal:  No To Hattatsu       Date:  1984

8.  Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo.

Authors:  Jong M Rho; Gail D Anderson; Sean D Donevan; H Steve White
Journal:  Epilepsia       Date:  2002-04       Impact factor: 5.864

9.  Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor.

Authors:  Lane Bekar; Witold Libionka; Guo-Feng Tian; Qiwu Xu; Arnulfo Torres; Xiaohai Wang; Ditte Lovatt; Erika Williams; Takahiro Takano; Jurgen Schnermann; Robert Bakos; Maiken Nedergaard
Journal:  Nat Med       Date:  2007-12-23       Impact factor: 53.440

10.  Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner.

Authors:  Lori-An V Etherington; Bruno G Frenguelli
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

View more
  5 in total

1.  Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency.

Authors:  Marcello Scala; Saskia B Wortmann; Namik Kaya; Menno D Stellingwerff; Angela Pistorio; Emma Glamuzina; Clara D van Karnebeek; Cristina Skrypnyk; Katarzyna Iwanicka-Pronicka; Dorota Piekutowska-Abramczuk; Elżbieta Ciara; Frederic Tort; Beth Sheidley; Annapurna Poduri; Parul Jayakar; Anuj Jayakar; Jariya Upadia; Nicolette Walano; Tobias B Haack; Holger Prokisch; Hesham Aldhalaan; Ehsan G Karimiani; Yilmaz Yildiz; Ahmet C Ceylan; Teresa Santiago-Sim; Amy Dameron; Hui Yang; Mehran B Toosi; Farah Ashrafzadeh; Javad Akhondian; Shima Imannezhad; Hanieh S Mirzadeh; Shazia Maqbool; Aisha Farid; Mohamed A Al-Muhaizea; Meznah O Alshwameen; Lama Aldowsari; Maysoon Alsagob; Ashwaq Alyousef; Rawan AlMass; Aljouhra AlHargan; Ali H Alwadei; Maha M AlRasheed; Dilek Colak; Hanan Alqudairy; Sameena Khan; Matthew A Lines; M Ángeles García Cazorla; Antonia Ribes; Eva Morava; Farah Bibi; Shahzad Haider; Matteo P Ferla; Jenny C Taylor; Hessa S Alsaif; Abdulwahab Firdous; Mais Hashem; Chingiz Shashkin; Kairgali Koneev; Rauan Kaiyrzhanov; Stephanie Efthymiou; Queen Square Genomics; Thomas Schmitt-Mechelke; Andreas Ziegler; Mahmoud Y Issa; Hasnaa M Elbendary; Pasquale Striano; Fowzan S Alkuraya; Maha S Zaki; Joseph G Gleeson; Tahsin Stefan Barakat; Jorgen Bierau; Marjo S van der Knaap; Reza Maroofian; Henry Houlden
Journal:  Hum Mutat       Date:  2022-01-12       Impact factor: 4.700

Review 2.  Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.

Authors:  Ning Cheng; Jong M Rho; Susan A Masino
Journal:  Front Mol Neurosci       Date:  2017-02-21       Impact factor: 5.639

3.  Ketogenic diet improves core symptoms of autism in BTBR mice.

Authors:  David N Ruskin; Julia Svedova; Jessica L Cote; Ursula Sandau; Jong M Rho; Masahito Kawamura; Detlev Boison; Susan A Masino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

4.  Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation.

Authors:  Mark D Smith; Dhaval P Bhatt; Jonathan D Geiger; Thad A Rosenberger
Journal:  J Neuroinflammation       Date:  2014-06-04       Impact factor: 8.322

5.  Ketogenic diet sensitizes glucose control of hippocampal excitability.

Authors:  Masahito Kawamura; David N Ruskin; Jonathan D Geiger; Detlev Boison; Susan A Masino
Journal:  J Lipid Res       Date:  2014-08-28       Impact factor: 5.922

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.